GL1X · GenesisL1 explorer

MolNFT v1 · #67317 · protein

Crystal structure of HCV NS5B polymerase with a novel monocyclic dihydro-pyridinone inhibitor

3IGV · RNA-directed RNA polymerase: “Crystal structure of HCV NS5B polymerase with a novel monocyclic dihydro-pyridinone inhibitor”. X-ray diffraction, 1 ligand (B80), 12 pockets (best druggability 0.80). MolNFT v1 #67317 on GenesisL1: 3D…

PDB
3IGV
Type
protein
Length
1,114 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
RNA-directed RNA polymerase
EC
2.7.7.48
UniProt
P26663
Ligands
B80
Pockets
12 · best druggability 0.80

Structure

x-ray diffraction · 1 distinct chain · 48% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BRNA-directed RNA polymerase (EC 2.7.7.48)protein55748% helix, 14% strandP26663

Ligands and binding sites

  • B80 · N-{3-[(6S)-6-ethyl-1-(4-fluorobenzyl)-4-hydroxy-2-oxo-1,2,5,6-tetrahydropyridin-3-yl]-1,1-dioxido-2H-1,2,4-benzothiadiazin-7-yl}methanesulfonamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

12 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111260.800.8182B80
210160.800.8176B80
38910.730.7893empty
43280.680.8237empty
51210.520.8117empty

Interfaces

1 interface between chains.

  • A–B · 613 Ų buried · 9 hydrogen bonds · protein-protein

Compared structures

  • 3IGV · Crystal structure of HCV NS5B polymerase with a novel monocyclic dihydro-pyridi inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.